The Role of Gut Microbiota Modification in Nonalcoholic Fatty Liver Disease Treatment Strategies
One of the most common chronic liver diseases is nonalcoholic fatty liver disease (NAFLD), which affects many people around the world. Gut microbiota (GM) dysbiosis seems to be an influential factor in the pathophysiology of NAFLD because changes in GM lead to fundamental changes in host metabolism....
Saved in:
Main Authors: | Hessam Yaghmaei, Amirhossein Bahanesteh, Masood Soltanipur, Sobhan Takaloo, Mahdi Rezaei, Seyed Davar Siadat |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | International Journal of Hepatology |
Online Access: | http://dx.doi.org/10.1155/2024/4183880 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Response to: Comment on “Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease”
by: Stefano Bibbò, et al.
Published: (2018-01-01) -
The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background
by: Jinsheng Yu, et al.
Published: (2016-01-01) -
Saikosaponin D improves nonalcoholic fatty liver disease via gut microbiota-bile acid metabolism pathway
by: Lan Li, et al.
Published: (2024-09-01) -
Long-Term Effects of Metformin and Lifestyle Modification on Nonalcoholic Fatty Liver Disease Obese Adolescents
by: Lian Tock, et al.
Published: (2010-01-01) -
From the Role of Microbiota in Gut-Lung Axis to SARS-CoV-2 Pathogenesis
by: Sara Ahmadi Badi, et al.
Published: (2021-01-01)